Navigation Links
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce,Positive Results of Phase III Study for Milnacipran as a Treatment,for Fibromyalgia Syndrome

ducts

Forest Laboratories (www.frx.com) is a US-based pharmaceutical company dedicated to identifying, developing and delivering products that make a positive difference in peoples' lives. Forest Laboratories' growing product line includes Lexapro(R) (escitalopram oxalate), an SSRI indicated for adults for the initial and maintenance treatment of major depressive disorder and generalized anxiety disorder; Namenda(R) (memantine HCl), an N-methyl D- aspartate (NMDA)-receptor antagonist indicated for the treatment of moderate to severe Alzheimer's disease; Benicar(R)* (olmesartan medoxomil), an angiotensin receptor blocker, and Benicar* HCT(R) (olmesartan medoxomil- hydrochlorothiazide), an angiotensin receptor blocker and diuretic combination product, each indicated for the treatment of hypertension; and Campral(R)* (acamprosate calcium), indicated in combination with psychosocial support for the maintenance of abstinence from alcohol in patients with alcohol dependence who are abstinent at treatment initiation.

    * Benicar is a registered trademark of Daiichi Sankyo, Inc., and Campral

      is a registered trademark of Merck Sante s.a.s., subsidiary of Merck

      KGaA, Darmstadt, Germany.

Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products, and the risk factors listed from time to time in the Forest Laboratories' SEC reports, including the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2006 and on Form 10-Q for the periods ended June 30, 2006, September 30, 2006
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
2. Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. Positive Aggrastat Results Featured in the Journal of the American College of Cardiology
6. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
7. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:9/19/2014)... VIENNA , Sept. 19, 2014 ... positive interim clinical data for its lead candidate ITCA ... diabetes patients with high baseline HbA1c levels at the ... for the Study of Diabetes (EASD). Data from the ... reduced levels of blood sugar in patients with poorly ...
(Date:9/19/2014)... and CAMBRIDGE, Mass. ... Inc. (PGDx), a provider of advanced cancer ... Medicines , a leader in discovering and developing ... today disclosed the first-ever comprehensive genomic study of ... deadly cancer of the female reproductive system, also ...
(Date:9/19/2014)... Sept. 19, 2014  PCI is pleased to ... Biotec is a leading provider of Clinical Trial ... Bridgend, Wales in the ... significantly expands PCI,s presence in the UK/EU to ... adding packaging, storage and distribution capacity, as well ...
Breaking Medicine Technology:Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 2Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 3Intarcia Announces Presentation of Phase 3 Data at EASD Showing ITCA 650 Markedly Reduces Blood Sugar In Patients With Poorly Controlled Type 2 Diabetes 4First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 2First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 3First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines 4PCI Announces Acquisition Of Biotec 2PCI Announces Acquisition Of Biotec 3PCI Announces Acquisition Of Biotec 4PCI Announces Acquisition Of Biotec 5PCI Announces Acquisition Of Biotec 6
(Date:9/21/2014)... 21, 2014 Originally approved by ... GSK’s Flovent (fluticasone propionate) is a synthetic ICS ... for the maintenance treatment of asthma prophylactically in ... two formulations, Diskus and HFA, which received the ... active ingredient, fluticasone propionate, can bind to glucocorticoid ...
(Date:9/21/2014)... 2014 To accommodate the ever-growing customer ... provide more trendy items. Recently, the company has unveiled ... the new and elegant wedding gowns, Angeldress.co.uk wants to ... need in an easy way. Its high quality vintage ... from 12% off to 62% off. , Online shopping ...
(Date:9/21/2014)... New York, NY (PRWEB) September 21, 2014 ... ( http://www.thegranuflolawsuit.com/ ) have been added over the ... involving claims that allege serious cardiovascular injuries caused ... , A Case List updated on September 15th ... underway in the U.S. District Court, District of ...
(Date:9/21/2014)... “Cluster headaches are sometimes called ‘Suicide Headaches’ because ... said Steve Young of Ew Publishing; “I’ve had cluster ... is more intense.” , “It should be a relief ... that medical research is pointing to some relief and ... Serotonin (5-HT, 5-hydroxytryptamine) is a ubiquitous biochemical found in ...
(Date:9/21/2014)... Developers and plugin specialist of Final ... transition plugin entitled Transpack Vol. 3 from Pixel Film ... that will add a level of professionalism to any ... Film Studios. “Blurring the line between professional and armature, ... Transpack Vol. 3 returns with over 85 all new ...
Breaking Medicine News(10 mins):Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 2Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 3Health News:Flovent Asthma Market Sales & SWOT Analysis and Forecasts to 2023 in New Report Available at LifeScienceIndustryResearch.com 4Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 2Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 3Health News:Federal GranuFlo Litigation Adds Dozens of Cases Alleging Serious Cardiovascular Injuries, Bernstein Liebhard LLP Reports 4Health News:Homeostasis: Equinox Serotonin (5HT) Headache Stories ~ New on the Bryan William Brickner Blog 2Health News:Pixel Film Studios Released Transpack Vol. 3 Plugin Exclusively for Final Cut Pro X 2
... benefit from liver supportive liver therapy while ... to enable bridging to liver transplantation. Albumin ... and renal function as well as the ... hemodynamic alterations in stable patients with cirrhosis ...
... Digestive Disease Week (DDW), SAN DIEGO, May ... Disease Week meeting that showed Cimzia(R) (certolizumab pegol),provided ... than 60 percent,of Crohn,s disease patients who were ... percent of patients achieved remission by six weeks.,Data ...
... Depression is a serious,but treatable health condition that ... be the focus of a national campaign during Mental,Health ... is,supported by the Anthem Blue Cross Foundation, the charitable ... Depression National Awareness Campaign is an effort to,increase knowledge, ...
... to introduce local physicians to new facility, SAN CARLOS, ... of its newest facility in San Carlos, welcoming doctors,located within ... was on hand to mingle with guests and provide tours ... were in attendance to learn about,SleepQuest,s services and the benefits ...
... Ltd. (Amex: CPD ) announced that the ... fiscal year 2008 ended March 31, 2008,prior to ... Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops,manufactures, markets ... largest wholesalers, distributors,drugstore chains and managed care providers., ...
... find tissue that normally lines the stomach in locations outside ... identified in such diverse locations as the scrotum, the gall ... a team led by Dr. Steven Paul Schmidt, is described ... of Gastroenterology. , Typically, when this gastric tissue is located ...
Cached Medicine News:Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 2Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 3Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 4Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 5Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 6Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 7Health News:Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients 8Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 2Health News:Anthem Blue Cross Foundation Supports National Campaign Focused on Depression Among Men 3Health News:SleepQuest Holds Open House 2Health News:Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008 2Health News:Heterotopic gastric tissue simulating acute appendicitis 2
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek Therapeutic Drug Monitoring Control (TDM) contains over 40 analytes with assayed values at three clinically significant levels....
... Urine Control contains a comprehensive ... that monitor tests for general ... hormones. It also contains hCG ... microalbumin at levels suitable for ...
qUAntify Control is designed to monitor the performance of urine dipstick testing. The control is available in 12 mL ready-to-use dropper bottles....
Medicine Products: